RA CAPITAL MANAGEMENT, L.P.
Total Volume
$1.8B
50 filings
Purchases
$687.3M
38 buy txns
Sales
$108.8M
38 sell txns
Net Activity
$578.6M
net bought
Profile
- Filings
- 50
- Buy transactions
- 38
- Sell transactions
- 38
- Companies
- 24
- Active
- 2025–2026
RA CAPITAL MANAGEMENT, L.P. has filed 50 reports across 24 companies, totaling $1.8B in disclosed volume. The predominance of buying ($687.3M in purchases vs. $108.8M in sales) may reflect confidence in the underlying companies. All data sourced from SEC Form 3, 4, and 5 filings.
Associated Companies
Cidara Therapeutics, Inc. (CDTX)
1 filing
$1.0B
Parabilis Medicines, Inc. (PBLS)
3 filings
$424.2M
$423.8M bought
Artiva Biotherapeutics, Inc. (ARTV)
3 filings
$87.3M
$87.3M bought
SpyGlass Pharma, Inc. (SGP)
3 filings
$59.5M
$59.0M bought
Fulcrum Therapeutics, Inc. (FULC)
1 filing
$58.4M
Hemab Therapeutics Holdings, Inc. (COAG)
6 filings
$55.5M
$55.5M bought
Wave Life Sciences Ltd. (WVE)
1 filing
$54.6M
$54.6M bought
Vor Biopharma Inc. (VOR)
6 filings
$50.2M
Acrivon Therapeutics, Inc. (ACRV)
2 filings
$7.0M
Bicara Therapeutics Inc. (BCAX)
2 filings
$5.2M
$4.8M bought
Adicet Bio, Inc. (ACET)
2 filings
$1.6M
$1.6M bought
Climb Bio, Inc. (CLYM)
4 filings
$1.2M
$779.6K bought
Evommune, Inc. (EVMN)
1 filing
$1000.0K
Werewolf Therapeutics, Inc. (HOWL)
4 filings
$963.9K
Sionna Therapeutics, Inc. (SION)
1 filing
$636.9K
Tyra Biosciences, Inc. (TYRA)
1 filing
$430.1K
ARS Pharmaceuticals, Inc. (SPRY)
1 filing
$316.2K
Janux Therapeutics, Inc. (JANX)
1 filing
$211.7K
LENZ Therapeutics, Inc. (LENZ)
1 filing
$146.5K
Acumen Pharmaceuticals, Inc. (ABOS)
1 filing
$121.9K
Nkarta, Inc. (NKTX)
1 filing
$91.0K
PepGen Inc. (PEPG)
1 filing
$60.9K
Prelude Therapeutics Inc (PRLD)
2 filings
$141
Solid Biosciences Inc. (SLDB)
1 filing
$0
Trading History
| Jun 26 | SPRY ARS Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $0 |
| Jun 24 | SLDB Solid Biosciences Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $0 |
| Jun 22 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Sell | $145.9K |
| Jun 22 | PEPG PepGen Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $0 |
| Jun 22 | ACRV Acrivon Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $0 |
| Jun 18 | SION Sionna Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $0 |
| Jun 17 | COAG Hemab Therapeutics Holdings, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $1.7M |
| Jun 16 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $4.6M |
| Jun 16 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Sell | $173.8K |
| Jun 15 | LENZ LENZ Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $0 |
| Jun 15 | PBLS Parabilis Medicines, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $423.8M |
| Jun 12 | JANX Janux Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Grant | $0 |
| Jun 12 | VOR Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $0 |
| Jun 11 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Sell | $253.6K |
| Jun 11 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $7.7M |
| Jun 11 | PBLS Parabilis Medicines, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $0 |
| Jun 11 | NKTX Nkarta, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $0 |
| Jun 10 | BCAX Bicara Therapeutics Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $0 |
| Jun 9 | PBLS Parabilis Medicines, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $0 |
| Jun 8 | CLYM Climb Bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $0 |
| Jun 5 | ABOS Acumen Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Grant | $0 |
| Jun 1 | TYRA Tyra Biosciences, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $0 |
| May 21 | COAG Hemab Therapeutics Holdings, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $119.8K |
| May 14 | COAG Hemab Therapeutics Holdings, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $159.0K |
| May 13 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $75.0M |
| May 12 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Sell | $390.7K |
| May 11 | COAG Hemab Therapeutics Holdings, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $1.3M |
| May 6 | COAG Hemab Therapeutics Holdings, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $52.2M |
| Apr 30 | COAG Hemab Therapeutics Holdings, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $0 |
| Apr 29 | CLYM Climb Bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $0 |
| Apr 28 | PRLD Prelude Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $0 |
| Apr 28 | PRLD Prelude Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $0 |
| Apr 24 | VOR Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Sell | $2.6M |
| Apr 23 | ACRV Acrivon Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Grant | $7.0M |
| Apr 21 | VOR Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Sell | $10.2M |
| Apr 15 | VOR Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Sell | $11.9M |
| Apr 13 | ACET Adicet Bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $1.6M |
| Apr 13 | ACET Adicet Bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $0 |
| Apr 10 | VOR Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Sell | $10.2M |
| Apr 6 | VOR Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Sell | $14.5M |
| Mar 30 | WVE Wave Life Sciences Ltd. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $54.6M |
| Mar 2 | BCAX Bicara Therapeutics Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $4.8M |
| Feb 17 | EVMN Evommune, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Grant | $1000.0K |
| Feb 11 | SGP SpyGlass Pharma, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $59.0M |
| Feb 9 | SGP SpyGlass Pharma, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $0 |
| Feb 5 | SGP SpyGlass Pharma, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $0 |
| Jan 9 | CDTX Cidara Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $0 |
| Jan 7 | CLYM Climb Bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $24.9K |
| Dec 15 | CLYM Climb Bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $754.7K |
| Dec 10 | FULC Fulcrum Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Sell | $58.4M |
50 filings+